Mitomics MDNA Moves Into Liquid Biopsy Market With New Prostate Cancer Test Premium The company has rededicated itself to a fully blood-based test pipeline, with its next assays focused on women's health, including endometriosis and ovarian, uterine, and cervical cancers. In Brief This Week: Mitomics, Sterling Pathology National Laboratories; J. Craig Venter Institute, CLC Bio; LabCorp NEW YORK (GenomeWeb News) – Mitomics said this week it has entered into a sales and marketing deal with Sterling Pathology National Laboratories covering Mitomics' Prostate Core Mitomic Test. Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay Premium Akonni Biosystems this week announced the results of three preclinical studies in support of the efficacy of its TruDiagnosis molecular diagnostics platform and TruArray tests, and said that the platform is now ready for expanded, multi-site clin CML HealthCare to Offer Mitomics Prostate Test in Canada NEW YORK (GenomeWeb News) – CML HealthCare today said that it has licensed exclusive rights to offer Mitomics' prostate cancer test in Canada. Mitomics Inks Sales and Marketing Deal with LabCorp NEW YORK (GenomeWeb News) – Mitomics today announced a deal with Laboratory Corporation of America to offer Mitomics' molecular prostate cancer test. Sep 17, 2012 Mitomics Realigns, Eliminates Eight Positions Feb 16, 2012 Dx Focus: LabMD to Distribute Mitomics' Prostate Test; Lab21's NSCLC Companion Dx Test Premium Feb 14, 2012 Mitomics Inks US Marketing Deal for Prostate Test Nov 2, 2011 Bostwick Marketing Mitomics' Prostate Cancer Dx in the US May 19, 2011 QDx Pathology to Market Mitomics' PCR-Based Mitochondrial DNA Prostate Cancer Test in US Premium May 19, 2011 Mitomics, QDx Ink Development, Marketing Pact Mar 31, 2011 Mitomics Launches Test for Detecting Prostate Cancer from Negative Biopsies Premium Jul 16, 2010 People In The News: Jul 16, 2010 Jul 15, 2010 Mitochondrial Genomics Firm Eyes MDx for Cancer Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.